Patent classifications
A61K2800/74
Oral care compositions
Described herein are complexes comprising a cationic antibacterial agent and a metal salt; oral care compositions comprising same; along with methods of making and using these complexes and compositions.
Protectants
The present invention relates to the use of natural protectants comprising (i) a cetylpyridinium salt (such as cetylpyridinium chloride) or p-anisic acid or a salt thereof (such as sodium p-anisate) and (ii) piroctone olamine to prevent microbial growth in a product, such as a personal care product.
Silver Fluoride Formulations, Methods and Devices for Caries Management
An oral care formulation includes an aqueous mixture of a water-soluble silver salt, a fluoride reagent, and a water-soluble polymer, the aqueous mixture having a viscosity ranging from about 1000 cPs to about 35,000 cPs. A method of using a fluoride and silver containing formulation, such as silver diamine fluoride, in dental applications includes providing a substrate having the formulation in a solid or semi-solid state on a portion of the substrate, positioning the substrate adjacent to dental areas, and allowing the portion of the substrate with the formulation to contact the dental areas. A disposable applicator for applying the formulation is also disclosed.
TOPICAL MACQUI BERRY FORMULATION
The present invention provides a topical formulation and method of use where the formulation comprises macqui berry or a macqui berry extract containing anthocyanins having a very high oxygen radical absorbance capacity (ORAC). The formulation provides the macqui berry in a stabilized form which includes a glucuronide or glycuronide, a photostabilizing agent, encapsulation, or light- and/or air-blocking packaging.
Cosmetic uses of swertiamarin
The present invention relates to the uses of swertiamarin or of a plant extract enriched with swertiamarin, for stimulating the formation or regeneration of the epidermis and/or for stimulating the metabolism of the dermis mainly in the cosmetics field.
Stable silk protein fragment compositions
A composition is disclosed that includes pure silk fibroin-based protein fragments that are substantially devoid of sericin, wherein the composition has an average weight average molecular weight ranging from about 17 kDa to about 38 kDa, wherein the composition has a polydispersity of between about 1.5 and about 3.0, wherein the composition is substantially homogeneous, wherein the composition between 0 ppm to about 500 ppm of inorganic residuals, and wherein the composition includes between 0 ppm to about 500 ppm of organic residuals.
Stable silk protein fragment compositions
A composition is disclosed that includes pure silk fibroin-based protein fragments that are substantially devoid of sericin, wherein the composition has an average weight average molecular weight ranging from about 17 kDa to about 38 kDa, wherein the composition has a polydispersity of between about 1.5 and about 3.0, wherein the composition is substantially homogeneous, wherein the composition between 0 ppm to about 500 ppm of inorganic residuals, and wherein the composition includes between 0 ppm to about 500 ppm of organic residuals.
Agent for use for inflammatory conditions of mucous membranes
The present invention relates to an agent comprising anion-exchange groups that are suitable for adsorbing bacterial lipopolysaccharides (LPS) and/or lipoteichoic acids (LTA), for use in the prevention and/or treatment of inflammatory conditions and/or diseases of the oral cavity or in the vaginal region. The present invention also relates to a pharmaceutical composition that comprises an agent of this kind and can adhere to mucosa.
ORAL RINSE COMPOSITION, ORAL CLEANSING KIT, METHOD OF CLEANSING ORAL CAVITY AND METHOD OF MAKING ORAL RINSE COMPOSITION
An oral rinse composition includes a solution containing an active ingredient, a humectant, flavoring, and water. An oral cleansing kit includes a container and an oral rinse composition in the container. A method of cleansing an oral cavity includes applying an oral rinse composition to an oral cavity. A method of making an oral rinse composition includes combining a humectant, flavoring, water, and an active ingredient.
NOVEL GINSENOSIDE AND ANTI-INFLAMMATORY COMPOSITION COMPRISING SAME
The present specification relates to (20S,24R)-6-O-β-D-glucopyranosyl(1->2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof. The novel ginsenoside exhibits excellent anti-inflammatory effects.